Skip to content

In response to the European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee recommendations in May 2020, BMS, IMS, EMAS, RCOG and AMS have produced a joint statement  on menopausal hormone therapy (MHT) and breast cancer risk.

View the full statement

International Menopause Society

Install International Menopause Society - DEV

Install this application on your home screen for quick and easy access when you’re on the go.

Just tap then “Add to Home Screen”